CORT · Insider trading · 13F holders · Congress trades
Corcept Therapeutics Inc (CORT)
Who is buying and selling CORT: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 24
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $53.9M
- Congress trades, 12 months
- 0
CORT at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 9 CORT insiders filed 21 sales worth $53.9M on SEC Form 4, and no open-market purchases; 18 of the sales were pre-planned under Rule 10b5-1.
- 24 13F filers hold CORT among their 50 largest positions, worth $2.0B combined, including Jim Simons and Joseph Edelman. The biggest bets by portfolio weight are Ingalls & Snyder LLC (18.9%), Tanaka Capital Management Inc (7.5%) and Propel Bio Management, LLC (6.2%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
- No member of Congress has disclosed a trade in CORT.
- CORT last closed at $85.95 on Oct 29, 2026.
CORT insider trading
Between Aug 1, 2026 and Oct 29, 2026, 9 CORT insiders filed 21 sales worth $53.9M on SEC Form 4, and no open-market purchases; 18 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 16, 2026 | Wilson James N | Director | Sale10b5-1 | 10,000 | $114.81 | $1.1M | SEC |
| Oct 5, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 25,000 | $116.26 | $2.9M | SEC |
| Oct 5, 2026 | Lyon Joseph Douglas | See Remarks | Sale10b5-1 | 10,000 | $116.07 | $1.2M | SEC |
| Oct 5, 2026 | Vieira Roberto Wandenkolk | President, Oncology | Sale10b5-1 | 8,333 | $116.10 | $967K | SEC |
| Sep 18, 2026 | Vieira Roberto Wandenkolk | President, Oncology | Sale10b5-1 | 296 | $100.82 | $30K | SEC |
| Sep 16, 2026 | Lyon Joseph Douglas | See Remarks | Sale10b5-1 | 10,000 | $113.49 | $1.1M | SEC |
| Sep 16, 2026 | Wilson James N | Director | Sale10b5-1 | 10,000 | $110.69 | $1.1M | SEC |
| Sep 3, 2026 | Vieira Roberto Wandenkolk | President, Oncology | Sale10b5-1 | 58,333 | $110.76 | $6.5M | SEC |
| Sep 3, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 25,000 | $114.43 | $2.9M | SEC |
| Aug 28, 2026 | Park Kimberly | Director | Sale | 26,685 | $122.55 | $3.3M | SEC |
| Aug 27, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 30,955 | $125.58 | $3.9M | SEC |
| Aug 20, 2026 | Mahoney David L | Director | Sale10b5-1 | 103,606 | $118.25 | $12.3M | SEC |
| Aug 18, 2026 | Robb Gary Charles | Chief Business Officer | Sale | 10,000 | $116.26 | $1.2M | SEC |
| Aug 18, 2026 | Wilson James N | Director | Sale10b5-1 | 10,000 | $111.43 | $1.1M | SEC |
| Aug 18, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 3,664 | $114.49 | $419K | SEC |
| Aug 12, 2026 | Guyer William | Chief Development Officer | Sale10b5-1 | 16,300 | $113.43 | $1.8M | SEC |
| Aug 12, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 1,031 | $114.52 | $118K | SEC |
| Aug 6, 2026 | Guyer William | Chief Development Officer | Sale10b5-1 | 3,700 | $113.12 | $419K | SEC |
| Aug 5, 2026 | Maduck Sean | See Remarks | Sale10b5-1 | 20,305 | $114.70 | $2.3M | SEC |
| Aug 5, 2026 | Lyon Joseph Douglas | See Remarks | Sale | 1,540 | $114.16 | $176K | SEC |
| Aug 3, 2026 | Mokari Atabak | Chief Financial Officer | Sale10b5-1 | 80,000 | $114.71 | $9.2M | SEC |
Who owns CORT? Hedge funds and superinvestors
24 13F filers hold CORT among their 50 largest positions, worth $2.0B combined, including Jim Simons and Joseph Edelman. The biggest bets by portfolio weight are Ingalls & Snyder LLC (18.9%), Tanaka Capital Management Inc (7.5%) and Propel Bio Management, LLC (6.2%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
Superinvestors holding CORT: Jim Simons 0.6% · Joseph Edelman 0.5%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Ingalls & Snyder LLCInvestment manager | 18.9% | $689.9M | 7,934,507 | +4.3% shares | Q2 2026 |
| Jim SimonsHedge fund | 0.6% | $457.5M | 5,261,628 | -7.4% shares | Q2 2026 |
| Parallel Advisors, LLCWealth manager | 5.3% | $344.5M | 3,962,177 | -0.4% shares | Q2 2026 |
| Tang Capital Management LLCHedge fund | 6.0% | $130.4M | 1,500,000 | +0.0% shares | Q2 2026 |
| Mpm Bioimpact LLCHedge fund | 4.1% | $67.0M | 771,028 | -21.8% shares | Q2 2026 |
| Emerald Advisers, LLCInstitutional asset manager | 1.5% | $65.1M | 748,325 | — | Q2 2026 |
| Emerald Mutual Fund Advisers TrustMutual fund manager | 1.4% | $40.4M | 464,902 | — | Q2 2026 |
| Joseph EdelmanHedge fund | 0.5% | $34.6M | 398,385 | — | Q2 2026 |
| Boxer Capital Management, LLCHedge fund | 2.2% | $29.2M | 335,500 | +34.2% shares | Q2 2026 |
| FAS Wealth Partners, Inc.Wealth manager | 1.5% | $28.2M | 324,876 | +0.8% shares | Q2 2026 |
| Granite Investment Partners, LLCWealth manager | 0.8% | $15.0M | 172,228 | — | Q2 2026 |
| Propel Bio Management, LLCHedge fund | 6.2% | $11.9M | 136,499 | -7.7% shares | Q2 2026 |
| Brown Capital Management LLCMutual fund manager | 1.8% | $9.7M | 84,041 | +0.0% shares | Q3 2026 |
| O'Neil Global Advisors, Inc.Institutional asset manager | 1.9% | $8.6M | 98,334 | New | Q2 2026 |
| Lisanti Capital Growth, LLCInstitutional asset manager | 1.8% | $8.0M | 91,610 | — | Q2 2026 |
| Stanley-Laman Group, Ltd.Wealth manager | 0.8% | $7.6M | 66,365 | -2.7% shares | Q3 2026 |
| Bridge City Capital, LLCInstitutional asset manager | 1.6% | $7.6M | 65,530 | +21.8% shares | Q3 2026 |
| Birchview Capital, LPWealth manager | 2.3% | $5.0M | 57,200 | +21.2% shares | Q2 2026 |
| S&T Bank/PABank & trust | 1.4% | $4.8M | 55,553 | -18.4% shares | Q2 2026 |
| Tanaka Capital Management IncMutual fund manager | 7.5% | $4.5M | 110,854 | -0.2% shares | Q1 2026 |
| Simplify Asset Management Inc.Mutual fund manager | 0.0% | $2.4M | 20,568 | — | Q3 2026 |
| Illumine Investment Management, LLCWealth manager | 1.3% | $1.9M | 0 | — | Q3 2026 |
| Vilga Financial Planning LLCWealth manager | 0.9% | $1.5M | 13,046 | — | Q3 2026 |
| Englebert Financial Advisers, LLCWealth manager | 0.8% | $847K | 7,348 | — | Q3 2026 |
Each manager counts with its latest 13F (Q3 2026: 7, Q2 2026: 16, Q1 2026: 1). Screen CORT in the grand portfolio →
CORT stock trades by members of Congress
No member of Congress has disclosed a trade in CORT.
CORT questions and answers
Are insiders buying CORT stock?
Between Aug 1, 2026 and Oct 29, 2026, 9 CORT insiders filed 21 sales worth $53.9M on SEC Form 4, and no open-market purchases; 18 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own CORT?
24 13F filers hold CORT among their 50 largest positions, worth $2.0B combined, including Jim Simons and Joseph Edelman. The biggest bets by portfolio weight are Ingalls & Snyder LLC (18.9%), Tanaka Capital Management Inc (7.5%) and Propel Bio Management, LLC (6.2%). In their latest 13Fs, 1 manager opened a new position and 3 added to one.
Has Congress traded CORT?
No member of Congress has disclosed a trade in CORT.
Who is the largest holder of CORT?
Among 13F filers, Ingalls & Snyder LLC reports the largest CORT position, $689.9M (7,934,507 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Ingalls & Snyder LLC's: 18.9% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.